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Background/aim: MERTK, a tyrosine kinase receptor protein
expressed by the retinal pigment epithelium (RPE), is mutated
in both rodent models and humans affected by retinal
disease. This study reports a survey of families for Mertk
mutations and describes the phenotype exhibited by one
family.
Methods: 96 probands with retinal dystrophy, consistent with
autosomal recessive segregation, were screened by direct
sequencing. A family homozygous for a likely null allele was
investigated clinically.
Results: A novel frame shifting deletion was identified in one
of 96 probands. Other polymorphisms were detected. The
deletion allele occurred on both chromosomes of four
affected family members. Electrophysiology demonstrated
early loss of scotopic and macular function with later loss of
photopic function. Visual acuities and visual fields were
preserved into the second decade. Perception of light vision
was present in a patient in the fourth decade. A ‘‘bull’s eye’’
appearance and a hyperautofluorescent lesion at the central
macula were consistent clinical findings.
Conclusions: Mutations in Mertk are a rare cause of ARRP in
humans. The study extends the phenotypic characteristics of
this retinal dystrophy and shows distinctive clinical signs that
may improve its clinical identification. The moderate severity
and presence of autofluorescence implies that outer segment
phagocytosis is not entirely absent.
R
etinitis pigmentosa (RP) is a a group of disorders
affecting the retina in which there is progressive loss
of rod then cone photoreceptor cells, with consequent
loss of scotopic then photopic visual function. It affects
approximately one in 3500 people. Currently there are no
proved preventative or curative measures. It is highly
heterogeneous genetically, with over 35 genes causing non-
syndromic disease (http://www.retnet.org). This degree of
heterogeneity hinders efforts to obtain a molecular diagnosis.
Thus, we have adopted a strategy in which probands are
screened initially for mutations in genes that may in the
future be addressed with a specific therapeutic intervention.
In 2000, D’Cruz and colleagues identified Mertk as the gene
mutated in the Royal College of Surgeons (RCS) rat, a well
studied animal model of retinal degeneration.1 This model
develops a spontaneous retinal degeneration characterised by
the accumulation of debris between the retinal pigment
epithelium (RPE) and neurosensory retina with subsequent
death of the outer retina. The MERTK protein is a member of
the Axl/Mer/Tyro3 receptor tyrosine kinase family, is
expressed in RPE cells, and is required for phagocytosis, but
not binding of photoreceptor outer segments by the RPE.2
Importantly, the RCS rat has been widely used as a model for
the investigation of treatment strategies, including subretinal
transplantation of RPE cells and other cell lines,3 4 treatment
with growth factors such as bFGF,3 and gene replacement
therapies using viral vectors.5–7
Mutations in the human Mertk gene were first identified as
a cause of retinal disease by Gal and colleagues.8 They
identified three likely disease causing variants on five alleles
of three patients with recessive retinal dystrophy. A fourth
patient was later described in detail by McHenry and
colleagues.9 Here we describe four affected members of one
family who are homozygous for a single base deletion in the
Mertk gene. Mutation in Mertk causes a retinopathy with some
distinctive features. The milder phenotype shown by this
family compared to previous reports suggests the existence of
modifier influences and might allow a window of opportu-
nity for possible therapeutic intervention.
PATIENTS AND METHODS
A panel of 96 patients with simplex and autosomal recessive
retinal dystrophy were ascertained from the medical retinal
clinic at Moorfields Eye Hospital. There was no significant
bias between males or females in the panel, and the
likelihood of X linked disease in males was minimised by
examination of female relatives where possible. All patients
had a history and examination compatible with a retinal
dystrophy and abnormalities of both rod and cone full field
electroretinograms (ERGs). The study was conducted in
accordance with the tenets of the Declaration of Helsinki and
was approved by Moorfields Hospital ethics committee.
PCR and sequencing
Blood samples were collected in EDTA tubes and the DNA
was extracted using a Nucleon Genomic DNA Extraction Kit
(BACC2, Tepnel Life Sciences plc) following the manufac-
turer’s instructions.
Primers were designed corresponding to intronic sequences
for PCR amplification of all 19 exons of Mertk (table 1). All
polymerase chain reactions (PCR) were performed in a total
volume of 50 ml using 200 mM dNTPs (Promega UK), 0.5 mM
of each primer, 2 mM DNA, magnesium containing Optimase
reaction buffer (Transgenomic UK), and 2.5 U Optimase
polymerase (Transgenomic UK). Reactions were cycled using
a Techne Touchgene Thermal Cycler. Optimal annealing
temperatures were calculated using the program PrimerSelect
(DNAStar inc). Cycle conditions were 95 C˚ for 5 minutes, 30
cycles of 60 seconds/95˚ C, 15 seconds/annealing temperature,
15 seconds/72˚ C, and a final 10 minutes at 72˚ C.
Abbreviations: ARRP, autosomal recessive retinitis pigmentosa; ERGs,
electroretinograms; FFA, fluorescein angiography; HRR plates, Hardy-
Rand-Rittler plates; OCT, optical coherence tomography; PCR,
polymerase chain reaction; PERG, pattern ERGs; RCS, Royal College of
Surgeons; RP, retinitis pigmentosa; RPE, retinal pigment epithelium
718
www.bjophthalmol.com
Amplified DNA fragments were purified by ExoSAP-IT
(Usb Corporation) treatment in a total volume of 18 ml using
approximately 10 ng of DNA and 0.5 ml ExoSAP-IT enzyme
with sterile dH2O. The purification mix was incubated for
15 minutes at 37 C˚ and then the enzyme was inactivated for
15 minutes at 80 C˚. Samples were sequenced using a BigDye
Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems).
A volume of 1 ml Big Dye v1.1 and either 0.8 mM forward or
0.8 mM reverse primer were added to each ExoSAP IT treated
sample.
Cycling conditions were 30 seconds at 95 C˚, 30 seconds at
50 C˚, and 4 minutes at 60 C˚ for 30 cycles. Samples were
purified using a Millipore Montage Cleanup Kit (Millipore
Corporation) following the manufacturer’s instructions.
Samples were run overnight on an ABI Applied Biosystems
373A DNA Sequencer. Sequences were analysed using the
DNASTAR software package (DNASTAR Inc) and compared
to the normal human Mertk sequence (NT 022135).
Cryosections
Eyes from dystrophic RCS rats were prepared for cryosection-
ing. Sections 12 mm thick were mounted on to APES coated
slides, counterstained with propidium iodide, and analysed
using a Leitz Diaplan microscope fitted with appropriate
filters and a Leica DC 500 digital camera.
Clinical assessment
Individuals in which a pathogenic change was identified then
underwent more detailed clinical evaluation including slit lamp
examination, assessment of visual acuity, colour vision assess-
ment, and Goldmann field testing. Retinal imaging included
fundus autofluorescence imaging with a confocal scanning
laser ophthalmoscope (c-SLO-AF, HRA-2, Heidelberg engineer-
ing, Heidelberg Germany), standard clinical electroretinography
(ERG), fluorescein angiography (FFA) (proband only), and
optical coherence tomography (OCT).
Colour vision was evaluated using the Hardy-Rand-Rittler
(HRR) plates (American Optical Company, NY, USA).
Goldmann kinetic visual fields were determined using the
V4e and II4e targets on a standard background. ERG
assessment included full field pattern ERGs (PERG), per-
formed to incorporate the protocols recommended by the
International Society for Clinical Electrophysiology of Vision
Standard (http://iscev.org/standards/index.html). Corneal
gold foil recording electrodes were used for both full field
and pattern ERGs.
RESULTS
Molecular analysis
Of 96 samples screened for mutations in the coding and
splice site sequences of the Mertk gene, 11 variants from the
Genbank sequence (accession number NT022135 build 35
Table 1 Sequences and annealing temperature of primers
Mertk Forward primer 59-39 Reverse primer 59-39 Ta ( C˚)
Exon 1 gacaggttcgggaggtccatctg ccctgtggacgcgctccctccccag 60
Exon 2 ggacaccccagtgctctctcttc gtccaactgtgtgtttgaaggcaag 60
Exon 3 cacagcatatgacaaagaagttg cagagttataaataggcaggc 59
Exon 4 ctttgggctctgtctctgtttt ttgatcctgtccgctattagaga 52
Exon 5 tgtttctctgctgctggtctc cctcaccagctcccagaac 65
Exon 6 gtagctgtagcctgtcatctataa cccacagagagcaccaa 50
Exon 7 tgcctgacattcccaccac tgggaagggtttgttgaatca 65
Exon 8 atgagaatacatctgtgtgtgcttt agttgaaaggagatgactaatcg 50
Exon 9 ctgcagtttgcccagacctc gaccatcacatcctatcagccc 50
Exon 10 tgactatttgttcttccctgttac taacaaccttgtcaataccagtg 50
Exon 11 agtagccctgtttttatagtgaag gtctattgatccttctttgttctc 48
Exon 12 caagtgaaagaaaacacgctg aaactgctaccttcttatcccac 52
Exon 13 tggtcagggaagagtttgc gcacccaatactgaagcaac 52
Exon 14 cccacccactcccctt cacagagcagatcagcagag 60
Exon 15 tggtcacagtaacaaggactc tcacataagccctgagaagt 42
Exon 16 cccccggcagaaact tgcaaagaccaaacacca 58
Exon 17 gtgttttcacctgtgtctga tatgccctcctctttgtg 48
Exon 18 gctttgtggaaaggcttg tgtgtttccgaggtcagtg 50
Exon 19 ggcatggattgcacaaagagatgggtg catcaggtacaattggattctc 60
Primers were designed to cover the entire coding region and splice sites of the human Mertk gene using the
program PrimerSelect.
Table 2 Mertk sequence variants
Mutation/
polymorphism Exon Change Remark
Deletion 17 2214delT, C738W Frameshift, premature termination before codon 770.
Reported in this family
Missense 1 R20T Only found in 1 ARRP patient
Intronic IVS 1+19 gRa Equally prevalent in patients and controls
Missense* 2 N118S Equally prevalent in patients and controls
Intronic IVS 3+13 tRc Common polymorphism
Missense* 9 R466K Equally prevalent in patients and controls
Synonymous 9 Q451Q Not found in controls
Missense* 10 N498S Equally prevalent in patients and controls
Missense* 10 I518V Equally prevalent in patients and controls
Intronic IVS 15+11 tRc Common polymorphism
Missense* 19 V870I Equally prevalent in patients and controls
Sequence variants in Mertk were identified by sequencing DNA from individuals affected by RP. The table summarises all changes found in the present study.
*Also reported by Gal et al9 (adapted from Retina International’s Scientific Newsletter).
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version 1) were detected (table 2). Of these, four variants
would not be expected to change the sequence of the encoded
protein, being intronic or synonymous in nature. None of
these, however, has been reported previously. Six base
changes causing missense substitutions were found. Of
these, five had been reported previously and their prevalence
in 192 control chromosomes from people of white race not
significantly different from that of the 96 samples. The
remaining missense change, R20T, was detected on both
alleles of a 54 year old patient with severe autosomal
recessive retinitis pigmentosa. Sequence alignments showed
that this arginine is a fully conserved residue in all members
of the human axl protein subfamily but is not conserved
between different species. Furthermore, R20S is a known
polymorphism in the human Mertk gene.8 The substitution
was not found in 96 samples from white patients or in 41
samples from Pakistani patients.
Finally, we identified a novel frameshifting single base
deletion (2214delT) within exon 17 of the Mertk gene in both
alleles of a patient with RP. This sequence change would
cause a premature stop codon (TGA) 31 codons downstream
of the mutation and 41 base pairs upstream of the
penultimate splice site which may render the RNA a target
for nonsense mediated decay.10 11 If translated, the resulting
protein would contain 31 foreign amino acids and would lack
262 amino acids from the carboxyl end of the 999 amino acid
long protein. Sequence alignment of Mertk proteins show
that the mutation is located in a region that is fully conserved
between the human, chimpanzee, mouse, rat, and chicken
proteins (fig 1) and also highly conserved between other
members of the human axl subfamily of tyrosine receptor
kinases—namely, Axl and Tyro3.
All three affected siblings and one affected cousin were
homozygous for the deletion. The unaffected mother and
father were both heterozygotes. Figure 2 shows electrophero-
grams from a control sample, the probands’ mother and the
proband. The pedigree structure is shown in figure 3.
Clinical examinaton
The proband (IV:6, figure 3), a 19 year old girl of Middle
Eastern origin, was diagnosed with RP at the age of 12 years.
She had no significant history of systemic disease or of
medication. She noticed nyctalopia since she was 12 years
old, did not experience problems with navigation but found
reading fine detail difficult. At the age of 16 years, her best
corrected visual acuities were 20/30 right eye and 20/40 left
eye. Three years later (at age 19 years) her visual acuity had
not changed. There was no nystagmus and the anterior
segments were normal. Fundus examination showed atte-
nuated vessels, a pale reflex form the RPE, and a bull’s eye
lesion at the maculas (fig 4) There was no intraretinal
pigmentation (bone spicules), or macular oedema evident on
biomicroscopy.
Monocular perimetry (Goldmann, V4e, and II4e) showed
well preserved visual fields (fig 5). Colour vision assessment
with HRR plates showed both red-green and blue-yellow
Chicken
Rat
Mouse
Human
Mutation
Mertk sequence of different species
C738W
Stop
A
Mertk
Axl
Tyro3
Members of the human axl family
B
Figure 1 Amino acid sequences (aa735–aa775). Sequences were
aligned using SDSC Biology WorkBench. (A) Amino acid alignments of
different species show that the mutation occurred in a highly conserved
domain of MERTK. The predicted sequence caused by a single base pair
deletion of the affected probands is shown in the lowest line. The
mutation leads to a frameshift and a premature translation termination
signal within the tyrosine kinase domain of the protein. (B) Amino acid
sequence comparison of different members of the human axl tyrosine
kinase receptor family shows that the region in which the mutation
occurred is highly conserved between all members. This suggests that this
domain is important for proper function. *Single, fully conserved residue;
: , conservation of strong groups; . , conservation of weak groups
Figure 2 DNA sequence chromatograms (bp2207–bp2222). A novel
mutation was identified in a patient with RP. The deletion (2214delT) was
found in affected individuals (top). The sequence of the unaffected
mother (middle) and control are shown (bottom).
IV:1 IV:10IV:9
–/–
IV:8IV:7
–/–
IV:6
–/–
IV:5IV:4
–/–
IV:3IV:2
III:4
+/–
III:3
+/–
III:2III:1
II:7II:6II:5II:4II:3II:2II:1
I:3I:2I:1
Figure 3 Abridged pedigree structure. Circles represent females and
squares represent males: open symbols, unaffected, solid symbols,
affected. Double lines indicate inter-related marriages.
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defects. Autofluorescent imaging of the RPE layer showed a
relatively homogeneous signal from the posterior pole but
was unusual in that it demonstrated a central area of
hyper-autofluorescence of approximately 500 mm in diameter
at the central macula (fig 6) encircled by an area of relative
decreased autofluorescence. Fluorescein angiography (at
16 years) showed a region of hypofluorescence at the central
macula throughout the transit (fig 6). There was no retinal
oedema. OCT was unremarkable and the retinal thickness
normal (data not shown). Electrophysiology (at 16 years)
showed a significant abnormality of both scotopic and
photopic ERGs. The attenuated 30 Hz flicker showed
significant delay. The pattern ERG was undetectable in
keeping with severe macular involvment (fig 7).
The proband’s affected younger sister (IV:7) was diagnosed
with RP at the age of 10 years. By age 14, she experienced
difficulty navigating and discerning colours in the dark, but did
not have problems reading. Her acuities were 20/30 in both eyes
best corrected (22D spheres both eyes). Fundus examination
was similar to her sister, although she had fine intraretinal
crystals present at the central macula. Goldmann perimetry,
colour vision, OCT imaging, and autofluorsecent imaging were
Figure 4 Fundus photographs from the three affected siblings. (A)
Fundus photograph of patient IV:6 showing attenuated vessels, a pale
reflex form the retinal pigment epithelium (RPE), and a bull’s eye lesion at
the macular. (B) Fundus photograph of patient IV:7 showing fine crystals
present at the central macula. (C) Fundus photograph of patient IV:9.
Figure 5 Goldmann visual fields. Monocular perimetry (Goldmann,
V4e and II4e) showing well preserved visual fields from patients IV:6 (A),
IV:7 (B), IV:9 (C).
Figure 6 Fundus autofluorescence and fundus fluorescein angiography
(FFA). (A) Fundus autofluorescence of patient IV:6 showing a bilateral
area of increased autofluorescence encircled by an area of relative
decreased signal. (B) FFA from patient IV:6 performed at the age of
16 years showing a region of hypofluorescence throughout the transit at
the central macula. (C) Fundus autofluorescence of patient IV:7. (D)
Fundus autofluorescence of patient IV:9 each shows a bilateral area of
increased autofluorescence encircled by an area of relative decreased
signal.
Retinal degeneration caused by Mertk gene mutation 721
www.bjophthalmol.com
also similar. ERG testing performed at the age of 10 years
showed attenuation of rod and cone responses, delay of the
cone implicit times, and barely detectable pattern ERGs.
The youngest affected sibling (IV:9) had noticed nyctalopia
by the age of 10 years but otherwise was asymptomatic. At this
age, his acuities were 20/20 in both eyes unaided. Fundus
examination revealed some pallor of the RPE in the peripheral
retina and some fine crystalline deposits near the fovea.
Goldmann perimetry, colour vision, OCT imaging, and auto-
fluorescent imaging were similar to his sisters although the area
of macular hyperautofluorescence was larger. Electrophysiology
showed an absent scoptic response, a severely attenuated
maximal response, and delayed and attenuated reponses to
photopic stimuli. The pattern ERG P50 was just recordable.
An older affected maternal half cousin of the proband
(IV:4) was unavailable for examination but gave a detailed
history at the age of 46 years. He started experiencing
problems seeing in the dark at the age of 9 years. Then, his
corrected visual acuities were normal. He was examined
extensively in his early teens but was not diagnosed with RP
until the age of 15 years. He learnt to drive, although he was
advised to stop at the age of 18 years. For the next few years
he managed well, attending university without assistance,
but by the age of 24 he benefited from the use of a closed
circuit TV monitor. At the age of 34 years, he required a
permanent guide for navigation. By the age of 38, he no
longer found use for his monitor owing to further deteriora-
tion of vision and, currently, at the age of 46 years only has
perception of light vision. There was no history of significant
systemic illness in any of the four affected individuals.
Retinal examinations of one other unaffected twin male
sibling (IV:8) and the mother (III:3) were both normal.
DISCUSSION
This study presents the first detailed clinical and molecular
report of multiple family members affected by RP caused by
mutation in the Mertk gene and describes a novel mutation.
Common to other reported surveys, the disorder is likely to be
a rare cause of autosomal recessive RP (ARRP). Only one
family was identified in a screen of 96 probands suggesting
that mutations in Mertk count for approximately 1% of
all ARRP. The possibility of heterozygous deletions or
duplications that affect primer binding sites cannot be
excluded. One previously unreported missense change,
R20T, was detected in this study on both alleles in one
person of Pakistani origin with ARRP. The fact that this
residue is polymorphic in the human population (R20S) and
that it is not conserved in other species suggests that it is
likely to be a non-disease causing variant although a rare one.
A hyperfluorescent area, situated at the central macula, of
up to half a disc area in size, was seen in the three affected
siblings. It was smaller in older individuals and showed
hypofluorescence on fluorescein angiography. This clinical
sign may represent debris from non-phagocytosed photo-
receptor discs lying between the RPE and neurosensory retina
with inherent autofluorescence but which masks choroidal
fluorescence during angiography. In support, the debris
characteristic of the degeneration in the RCS rat retina is
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Figure 7 Representative
electrophysiological traces. ERGs from
three patients showing a rod-cone
pattern of abnormality. Patient IV:6
shows no detectable rod specific ERG, a
severely reduced bright flash ‘‘mixed’’
ERG, profoundly reduced and delayed
30 Hz and single flash cone ERGs, and
an undetectable pattern ERG (PERG).
Overall, the findings are those of a
severe rod-cone dystrophy with severe
macular involvement. Patients IV:7 and
IV:9 also show severe rod system
dysfunction. There is better preservation
of generalised cone function than in
patient IV:6, but still with marked delay
and amplitude reduction. There is some
preservation of macular function shown
by the very low amplitude but
detectable PERGs
Figure 8 Fluorescence micrograph. The picture was taken of a 5 week
old dystrophic RCS rat. Owing to the phagocytotic defect of the RPE cells,
a debris layer consisting of broken off outer segment and membranous
waste material has accumulated. Photoreceptor outer segments and RPE
cells show strong autofluorescence, a characteristic feature of the
degenerating retina. INL, inner nuclear layer, OPL, outer plexiform
layer, ONL, outer nuclear layer, IS, inner segments, D, debris layer, RPE,
retinal pigment epithelium, C, choroid.
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also autofluorescent to light of a comparable wavelength
(fig 8). However, no such debris layer could be detected on
OCT examination. This sign may be useful in the clinical
identification of Mertk deficient disease when examining
families with RP. It should be emphasised that the
appearance of this ring is much smaller than that reported
by Robson et al and others which can occur in some patients
with RP.12 The homogeneous autofluorescence elsewhere
implies that phagocytosis of outer segments is not completely
deficient and in this regard would be different from the RCS
rat.
The disease observed in the three affected members
reported here, appears milder than those previously described
for a patient of comparable age with a different Mertk
genotype (R722X/R844C) who had vision reduced to 20/200
at 13 years and restricted visual fields.9 In contrast, the oldest
member of the present sibship maintained acuites of 20/20 at
the age of 18 years with more extensive visual fields.
Interestingly, a common feature is the appearance of a ring
of RPE depigmentation in a ‘‘bull’s eye’’ pattern on
funduscopy in all four photographed patients which in our
family corresponded to the area of hyper-autofluorescence.
This difference in severity may be the result of the influence
of genetic factors or environmental modifiers on the
expression of the Mertk deficiency, and these influences
may vary due to differences of ethnicity between reported
families. Alternatively, if RNAs expressed from the 2214delT
allele were to escape nonsense mediated decay, then part of
the tyrosine-kinase domain would remain intact and might
result in a partially functioning protein.13 Partial function is
less likely to follow expression of the R722X allele which is
significantly shorter, and so this might explain the relative
preservation of function of the family presented here
compared to that of the case reported by McHenry et al.9
The decline of retinal function, as measured by electro-
physiology, appears at an early stage in this family with loss
of both macular and scotopic function at the age of 5 years
(IV:9) accompanied by delay in the cone flicker ERG. By the
age of 16 years all responses were severely attenuated and
delayed. This early dysfunction, in which the rod system is
more affected than the cone system, is similar to that seen in
the rat and mouse models. The disorder can still progress
significantly as the older relative had perception of light in
his fourth decade. The preserved visual acuity and field into
the second decade suggests that the visual system develops
normally, an important consideration given the prospect of
therapeutic intervention. The detailed description of the
phenotype exhibited by the human Mertk mutation described
here might assist the identification of eligible patients and
families from among the many molecular types of RP.
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